Content

Welcome to the CJU website » LOG IN

Details

Pharmacology of phosphodiesterase 5 inhibitors
McGill University Health Centre, Montreal, Quebec, Canada
Feb 2003 (Vol. 10, Issue 11, Pages( 12 - 16)

Abstract

Text-Size + 

  • The phosphodiesterase enzymes, of at least 11 types, are ubiquitous throughout the body, and perform a variety of functions. Phosphodiesterase type 5 (PDE5) is the predominant enzyme in the corpus cavernosum, and plays a crucial role in penile erection. Inhibitors of PDE5 are the most effective oral agents in the treatment of erectile dysfunction. Sildenafil, tadalafil, and vardenafil are all potent inhibitors of PDE5 and show the same mechanism of action, although they have some pharmacological differences that may translate into varying clinical effects.

Current Issue

August 2019, Vol.26 No.4
canadian journal of urology